Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cleanroom Services Partnership Brings Synergy for Customers

Published: Thursday, May 01, 2014
Last Updated: Thursday, May 01, 2014
Bookmark and Share
Two award-winning laboratory service providers have joined forces to create greater synergy for customers.

Two award-winning laboratory service providers have joined forces to create greater synergy for customers. 


Cleanroom manufacturer Connect2Cleanrooms and specialist laboratory relocation provider Andrew Porter Limited have formed a partnership agreement, which is set to complement and enhance each firm’s service provision. 

Connect2Cleanrooms already provides disassembly, relocation and revalidation of its modular cleanrooms, but the new partnership with Andrew Porter Limited will enable it to offer a full relocation service to include all contents of the cleanroom, such as instrumentation and cold chain materials. 

Relocation of other laboratory spaces outside the cleanroom environment can also be provided, offering customers a turnkey solution. 

Andrew Porter Limited will be able to benefit customers through the partnership by providing modular cleanroom facilities, that could be used temporarily or part of a longer term proposition, for phased moves or where a decant into temporary premises is required as part of a larger relocation. 

This service will further enhance the range of additional services already provided by the company, with Connect2Cleanrooms also assisting Andrew Porter Limited in the training of its operatives to ISO14644-1:1999 EU GGMP, and US Federal standards 209E, where appropriate. 

European sales director at Andrew Porter Limited, John Best, commented: “We have a lot in common with Connect2Cleanrooms. We are both experts in our respective fields and are global companies which are headquartered in Lancashire, UK, so I am really pleased that we will be working together moving forward. 

“The technical specialism we are able to offer to each other’s customers makes this a mutually beneficial partnership that enhances both firms’ service offerings.” 

Joe Govier, managing director of Connect2Cleanrooms, said: “We first met with Andrew Porter Limited when we were both winners at this year’s Red Rose Awards. It is fantastic that the winning did not stop there for either of us and that this partnership will benefit both firms and our customer base now and into the future.” 


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Computerized Flexible Needles Prove Themselves in Biological Tissue
The advantage of the system is that you can avoid obstacles with the needles or critical tissues and that the system during the insertion of the needle in real time can adjust the path if, for example, the tissue deforms.
DARWIN 2 24-week Monotherapy Data in RA Confirm Previous Results
Safety profile in DARWIN 2 consistent with previous filgotinib RA studies.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Overdose of Vitamin D in Teenagers May Lead to Increased Cholesterol Levels
Dosing obese teens with vitamin D shows no benefits for their heart health or diabetes risk, and could have the unintended consequences of increasing cholesterol and fat-storing triglycerides. These are the latest findings in a series of Mayo Clinic studies in childhood obesity.
Phase 2 Trials Underway for New Single Dose Malaria Treatment
The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials in humans.
Promising Drug for Parkinson's Disease
A drug which has already been in use for decades to treat liver disease could be an effective treatment to slow down progression of Parkinson’s disease, scientists from the University of Sheffield have discovered.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!